by Kall Kwik WGC | Jul 10, 2017 | Free Library
June, 2017 SMM-162 Good news, bad news As the definition of value changes in life sciences, we can anticipate that, while the world is set to spend more on healthcare, the spend will be different.
by Kall Kwik WGC | May 29, 2017 | Free Library
May, 2017 SMM-161 Why Change Fails This article explores what evolutionary science can tell us about effecting real, valuable change in complex organisations.
by Kall Kwik WGC | May 3, 2017 | Free Library
April, 2017 SMM-160 The diseased organisation This feature article from PME uses my research on how organisations evolve to help you understand why things go wrong in companies. It will give you a new and useful perspective on the challenges you...
by Kall Kwik WGC | May 3, 2017 | Free Library
April, 2017 SMM-159 Reading the signals This is one of my regular Darwin’s Medicine columns and describes how you interpret the ‘weak signals’ that you see in your market to better understand and adapt your strategy.
by Kall Kwik WGC | Mar 6, 2017 | Free Library
February, 2017 SMM-158 Life Science’s Tangled Bank of Business Models The pharma industry is experiencing an explosion of new business models, more numerous and specialised than we’re used to. Companies need to pick the right model...
by Kall Kwik WGC | Mar 6, 2017 | Free Library
February, 2017 SMM-157 Six Big Shifts in Life Sciences It’s the question to which we all want the answer: Where is our industry headed? The answer is: Exactly where it is being pushed by what Charles Darwin called “immeasurably...
